Increase in Plasma Angiotensin II Levels After Chemical Blockade of AT1 Receptor Blockers,But Not With Antisense Oligodeoxynucleotide Directed at AT1 Receptor mRNA: A Major Benefit of Gene Therapy
Hokimoto S., Yasue H., Fujimoto K., et al. Expression of angiotensin-converting enzyme in remaining viable myocytes of human ventricles after myocardial infarction. Circulation94:1513, 1996
2.
TheSOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med325:293, 1991
3.
Pitt B., Segal R., Martinez FA, et al. Randomized trial of losartan versus captopril in patients over 65 with heart failure. Evaluation of losartan in the elderly study (ELITE) . Lancet349:747, 1997
4.
Goldberg MR, Tanka W, Barchosky, et al. Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers. Hypertension21:704, 1993
5.
Mehta JLModulation of arterial thrombosis by angiotensin converting enzyme inhibition and angiotensin II type I receptor blockade. Am J Cardiol82:53S-56S, 1998
6.
Yang BC, Phillips MI, Zhang YC, et al. Critical role of AT1 receptor expression after ischemia-reperfusion in isolated rat hearts: Beneficial effect of antisense oligodeoxynucleotides directed at AT1 receptor mRNA. Circ Res83:552, 1998
7.
Lu D., Yang H.Shaw G., et al. Angiotensin II-induced nuclear targeting of the AT1 receptor in brain neurons. Endocrinology139:1, 1998
